Astrana Health, Inc. logo

Astrana Health, Inc.

ASTH

NASDAQHealthcareMedical - Care Facilities

Previous close

$39.35

+$0.61 · +1.57%

Aug 21, 4:00 PM ET

ASTH company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

87

Deep Value

Momentum

71

Gaining

Sentiment

56

Mixed

Risk resilience

67

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Brandon K. Sim
Listed since
Mar 11, 2009
Employees
3,000

Market position

Day range

Current $39.35

52-week range

Current $39.35

Open
$38.83
Previous close
$38.74
Volume
395.14K
0.69× average
Average volume
573.53K
Average daily volume
Market cap
1.95B USD
Beta
0.9
Market reference 1
50-day average
$41.1978
-4.49% below average
200-day average
$30.7522
+27.96% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.87B USD
EV / EBITDA
13.79×
Earnings yield
1.85%
Free cash flow yield
8.58%

Profitability & efficiency

Return on equity
2.89%
Return on assets
1.01%
Return on invested capital
2.88%

Financial health

Current ratio
1.4×
Altman Z-score
2.86
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends25%16%7%-2%Gross margin, FY2021: 22.97%Gross margin, FY2022: 17.43%Gross margin, FY2023: 15.50%Gross margin, FY2024: 13.34%Gross margin, FY2025: 9.30%Operating margin, FY2021: 12.69%Operating margin, FY2022: 9.11%Operating margin, FY2023: 6.10%Operating margin, FY2024: 4.39%Operating margin, FY2025: 2.47%Net margin, FY2021: 8.91%Net margin, FY2022: 3.95%Net margin, FY2023: 4.38%Net margin, FY2024: 2.12%Net margin, FY2025: 0.71%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 22.97%. Gross margin FY2022 17.43%. Gross margin FY2023 15.50%. Gross margin FY2024 13.34%. Gross margin FY2025 9.30%. Operating margin FY2021 12.69%. Operating margin FY2022 9.11%. Operating margin FY2023 6.10%. Operating margin FY2024 4.39%. Operating margin FY2025 2.47%. Net margin FY2021 8.91%. Net margin FY2022 3.95%. Net margin FY2023 4.38%. Net margin FY2024 2.12%. Net margin FY2025 0.71%.

Income trends

Revenue

3.18B USD+56.39%

Operating income

78.53M USD-12.12%

Net income

22.49M USD-47.89%
Income trends across reported periods3.5B USD2.23B USD970.27M USD−293.44M USDRevenue, FY2021: 773.92M USDRevenue, FY2022: 1.14B USDRevenue, FY2023: 1.39B USDRevenue, FY2024: 2.03B USDRevenue, FY2025: 3.18B USDOperating income, FY2021: 98.18M USDOperating income, FY2022: 104.27M USDOperating income, FY2023: 84.61M USDOperating income, FY2024: 89.35M USDOperating income, FY2025: 78.53M USDNet income, FY2021: 68.92M USDNet income, FY2022: 45.17M USDNet income, FY2023: 60.72M USDNet income, FY2024: 43.15M USDNet income, FY2025: 22.49M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 773.92M USD. Revenue FY2022 1.14B USD. Revenue FY2023 1.39B USD. Revenue FY2024 2.03B USD. Revenue FY2025 3.18B USD. Operating income FY2021 98.18M USD. Operating income FY2022 104.27M USD. Operating income FY2023 84.61M USD. Operating income FY2024 89.35M USD. Operating income FY2025 78.53M USD. Net income FY2021 68.92M USD. Net income FY2022 45.17M USD. Net income FY2023 60.72M USD. Net income FY2024 43.15M USD. Net income FY2025 22.49M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue3.18B USD2.03B USD1.39B USD1.14B USD773.92M USD
Cost of goods sold2.89B USD1.76B USD1.17B USD944.69M USD596.14M USD
Gross profit295.78M USD271.39M USD214.96M USD199.48M USD177.77M USD
Selling, general, and administrative217.26M USD154.11M USD112.6M USD77.67M USD62.08M USD
Operating expenses217.26M USD182.04M USD130.35M USD95.21M USD79.59M USD
Interest income12.16M USD14.51M USD14.21M USD1.98M USD1.57M USD
Interest expense49.93M USD33.1M USD16.1M USD7.92M USD5.39M USD
Depreciation and amortization45.75M USD27.93M USD17.75M USD17.54M USD17.52M USD
Operating income78.53M USD89.35M USD84.61M USD104.27M USD98.18M USD
Net income22.49M USD43.15M USD60.72M USD45.17M USD68.92M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
55%
6 beats, 5 misses, 0 met estimates
Average EPS surprise
-24.32%
11 comparable reports
Latest EPS result
0.4
Estimate 0.34 · Beat by 19.12%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.520.280.04-0.2Q1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual -0.15, estimate 0.22, surprise -168.18%, Miss. Q2 2025, reported May 8, 2025: actual 0.14, estimate 0.23, surprise -39.13%, Miss. Q3 2025, reported Aug 7, 2025: actual 0.19, estimate 0.36, surprise -47.22%, Miss. Q4 2025, reported Nov 6, 2025: actual 0.01, estimate 0.47, surprise -97.87%, Miss. Q1 2026, reported Mar 2, 2026: actual 0.12, estimate 0.15, surprise -20.00%, Miss. Q2 2026, reported May 7, 2026: actual 0.3, estimate 0.29, surprise +3.45%, Beat. Q3 2026, reported Aug 6, 2026: actual 0.4, estimate 0.336, surprise +19.12%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.4, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.06B899.62M738.02M576.43MQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 665.21M USD, estimate 617.24M USD, surprise +7.77%, Beat. Q2 2025, reported May 8, 2025: actual 620.39M USD, estimate 630.68M USD, surprise -1.63%, Miss. Q3 2025, reported Aug 7, 2025: actual 654.81M USD, estimate 943.74M USD, surprise -30.62%, Miss. Q4 2025, reported Nov 6, 2025: actual 956.05M USD, estimate 930.47M USD, surprise +2.75%, Beat. Q1 2026, reported Mar 2, 2026: actual 950.53M USD, estimate 930.43M USD, surprise +2.16%, Beat. Q2 2026, reported May 7, 2026: actual 965.1M USD, estimate 949.21M USD, surprise +1.67%, Beat. Q3 2026, reported Aug 6, 2026: actual 972.5M USD, estimate 982.23M USD, surprise -0.99%, Miss. Q4 2026, reported Nov 5, 2026: actual —, estimate 1.02B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$51.80

31.64% upside
Past 12 months12-month forecastHigh $65.00Average $51.80Low $41.00

Rating distribution

10 ratings
Strong buy00%
Buy10100%
Hold00%
Sell00%
Strong sell00%

Recent analyst actions

9 institutions
NeedhammaintainBuy
JefferiesmaintainBuy

ASTH news

ASTH peers

ETFs holding ASTH

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research ASTH

research.disclaimer